Exosomes in ischemic heart disease: novel carriers for bioinformation
Publication date: December 2019Source: Biomedicine & Pharmacotherapy, Volume 120Author(s): Huan Zhou, Bin Wang, Yingxi Yang, Qiujin Jia, Zhongwen Qi, Ao Zhang, Shichao Lv, Junping ZhangAbstractThe occurrence of ischemic heart disease(IHD) is a multi-step chain process from potential risk factors to overt clinical diseases. Vascular cells, blood cells, cardiomyocytes and stem cells are all involved in the pathophysiological links via continual and polynary crosstalk. Exosomes,as powerful vectors for intercellular communication,have been a hotspot for basic and clinical research. Plenty of evidence has shown that exosomes largely participate in the evolution of IHD, including endothelial dysfunction, lipid deposition, atheromatous plaque formation and rupture, myocardial ischemia-reperfusion(I/R) injury,and heart failure (HF), while the rules for detailed communication in the different stages of this continuous disease are still poorly understood. This review will systematically describe characteristics of exosomal crosstalk between different cells in the diverse periods, and also cast light on the potential and challenges for exosome application as therapeutic targets, hoping to offer supporting background for the following research.
Source: Biomedicine and Pharmacotherapy - Category: Drugs & Pharmacology Source Type: research
More News: Cardiology | Drugs & Pharmacology | Heart | Heart Disease | Heart Failure | Stem Cell Therapy | Stem Cells